We are open with limited hours and staff.
Price range: $182.00 through $797.00
OxyContin OP 30mg provides oxycodone through a long-acting formulation. The current FDA labeling lists 30mg among the available OXYCONTIN strengths. Treatment should be individualized according to the patient’s pain, previous opioid exposure, medical history, response to treatment, and risk factors.
The medication should be taken exactly as prescribed. In addition, OXYCONTIN tablets must be swallowed intact. They should not be cut, broken, chewed, crushed, or dissolved because altering an extended-release tablet can release a potentially dangerous amount of oxycodone and increase overdose risk.
Therefore, patients should never change the prescribed strength or dosing schedule without guidance from a qualified healthcare professional. Ongoing treatment should also be reviewed regularly to assess pain control, adverse effects, and continued need for opioid therapy.
OXYCONTIN carries a boxed warning concerning addiction, abuse, misuse, overdose, and serious or potentially fatal respiratory depression. These risks can occur at any dosage or duration of treatment. Consequently, healthcare professionals should assess individual risk factors before and during therapy.
Common opioid-related effects may include drowsiness, dizziness, nausea, constipation, and sedation. However, unusually slow, shallow, or difficult breathing requires immediate medical attention.
Furthermore, combining oxycodone with alcohol, benzodiazepines, or other central nervous system depressants can increase the risk of profound sedation, respiratory depression, coma, and death. Patients should discuss all prescription medicines, nonprescription products, and other substances with their healthcare professional.
OxyContin OP 30mg should only be used according to an authorized prescription. Patients should keep the medication secure and never share it with another person. Safe storage also helps reduce accidental exposure, misuse, and unauthorized use.
Additionally, patients who have developed physical dependence should not abruptly stop treatment. Rapid dose reduction can cause withdrawal symptoms and uncontrolled pain. Instead, a healthcare professional can establish an appropriate gradual reduction plan when discontinuation becomes appropriate.
Patients and caregivers should also discuss opioid overdose reversal medicines, such as naloxone, with their healthcare professional. This can be particularly important when additional overdose risk factors are present.
